Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain

This publication has 29 references indexed in Scilit:

• Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse
  Journal of the Neurological Sciences, 1987
• Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum
  Life Sciences, 1987
• Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
  Annals of Neurology, 1986
• MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area
  Neuropharmacology, 1986
• Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys
  Neuroscience, 1986
• The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice antagonism by monoamine oxidase inhibitors
  Neuropharmacology, 1986
• The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum
  Journal of the Neurological Sciences, 1986
• The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset
  Neuroscience Letters, 1986
• Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones
  Biochemical Pharmacology, 1984
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979